Intrathecal clonidine and tizanidine in conscious dogs: Comparison of analgesic and hemodynamic effects

Anesthesia and Analgesia

Volumn 82, Issue 3, 1996, Pages 627-635

  Kroin, Jeffrey S ^a   McCarthy, Robert J ^a,b   Penn, Richard D ^a   Lubenow, Timothy R ^a   Ivankovich, Anthony D ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; CLONIDINE; DEXMEDETOMIDINE; GLYCOPYRRONIUM BROMIDE; IDAZOXAN; MORPHINE SULFATE; PRAZOSIN; SPASMOLYTIC AGENT; TIZANIDINE; YOHIMBINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ANTAGONISM; FEMALE; HEART RATE; HEMODYNAMICS; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS; ANIMALS; BLOOD PRESSURE; BRADYCARDIA; CLONIDINE; DIOXANES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCOPYRROLATE; HEART RATE; HEMODYNAMIC PROCESSES; IDAZOXAN; IMIDAZOLES; INJECTIONS, SPINAL; MALE; PARASYMPATHOLYTICS; REACTION TIME; SYMPATHOLYTICS; VAGUS NERVE; VASOCONSTRICTOR AGENTS; WAKEFULNESS; YOHIMBINE;

EID: 0029919024     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199603000-00035     Document Type: Article

References (24)

1. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
2. Milne B. Alpha-2 agonists and anaesthesia. Can J Anesth 1991;38:809-13.
3. Reddy SR, Maderdrut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther 1980;213:525-33.
4. Yaksh TL, Reddy SVR. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, α-adrenergic agonists, and baclofen. Anesthesiology 1981;54:451-67.
5. Coombs DW, Saunders RL, Lachance D, et al. Intrathecal morphine tolerance: use of intrathecal donidine, DADLE, and intraventricular morphine. Anesthesiology 1985;62:358-63.
6. Unnerstall JR, Kopajtic TA, Khar MJ. Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 1984;319:69-101.
7. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Phairnacol Biochem Behav 1985;22:845-58.
8. McCarthy RJ, Kroin JS, Lubenow TR, et al. Effect of intrathecal tizanidine on antinocieeption and blood pressure in the rat. Pain 1990;40:333-8.
9. Coward DM, Davies J, Herrling P, Rudeberg C. Pharmacological properties of tizanidine (DS 103-282). In: Conrad B, Benecke R, Bauer HJ, eds. Die klinische Wertung der Spastik. Stuttgart: Schattauer, 1984:61-9.
10. McCall RB. Central neurotransmitters involved in cardiovascular regulation. In: Antonaccio M, ed. Cardiovascular pharmacology. 3rd ed. New York: Raven Press, 1990:161-200.
11. 2-adrenoceptor agonist rilmenidine. Am J Cardiol 1988;61:6D-14D.
12. 2-adrenergic agonists. Anesthesiology 1991;74:766-71.
13. 2-adrenoceptors in the bradycardiac effects of clonidine and analogues. Arch Pharmacol 1981;317:8-12.
14. Castro MI, Eisenach JC. Pharmacokinetics and dynamics of intravenous, intrathecal, and epidural clonidine in sheep. Anesthesiology 1989;71:418-25.
15. Yasouka S, Yaksh TL. Effects on nociception threshold and blood pressure of itrathcally morphine and α-adrenergic agonists. Neuropharrriacology 1983;22:309-15.
16. Solomon RE, Brody MJ, Gerhart GF. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine. J Pharmacol Exp Ther 1989;251:27-38.
17. 2-type by B-HT 933. Eur J Pharmacol 1980;63:199-202.
18. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984;230:232-6.
19. Ernsberger P, Giuliano R, Willette RN, Reis DJ. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 1990;253:408-18.
20. Bloor BC, Frankland M, Alpier G, et al. Hemodynamic and sedative effects of desmedetomidine in dog. J Pharmacol Exp Ther 1992;263:690-7.
21. 2 receptor agonist dexmedetomidine in dogs. Anesthesiology 1994;80:1057-72.
22. Kroin JS, McCarthy RJ, Penn RD, et al. The effect of chronic subarachnoid bupivacaine infusion in dogs. Anesthesiology 1987;67:737-42.
23. Yaksh TL, Kohl RL, Rudy TA. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur J Pharmacol 1977;42:275-84.
24. 2-adrenoceptor antagonists in the decerebrated rabbit. Eur J Pharmacol 1993;237:323-8.